Morning Market Movers

Celldex Therapeutics CLDX surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer. Guanwei Recycling GPRC climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%. Geron GERN surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia. Intermec IN shares advanced 22.68% to $9.79. Honeywell International HON announced its plans to buy Intermec for $600 million.